Physician profile
Robert R Williams
NPI 1184682254
$2,386.38
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,929 · 2020: $457.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $469.64 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $412.18 | 2019-2020 | |
| Glaxosmithkline, LLC. | $345.42 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $226.58 | 2019-2020 | |
| Amgen INC. | $149.44 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $100.67 | 2019-2020 | |
| Novo Nordisk INC | $89.32 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $84.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $82.99 | 2019 | |
| Pfizer INC. | $76.95 | 2019-2020 | |
| Shire North American Group INC | $44.10 | 2019 | |
| Lilly USA, LLC | $41.20 | 2019-2020 | |
| Amarin Pharma, INC. | $39.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $36.00 | 2019 | |
| Smith+Nephew, INC. | $30.27 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $29.08 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $24.14 | 2019 | |
| Merck Sharp & Dohme LLC | $24.07 | 2019 | |
| Ironshore Pharmaceuticals INC. | $20.95 | 2019 | |
| Pacira Therapeutics, INC. | $19.23 | 2019 | |
| Hikma Pharmaceuticals USA | $17.48 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $10.89 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.